Pentraxin 3-a marker of diastolic dysfunction and HF?

Bernhard M. Kaess; Ramachandran S. Vasan

doi:10.1038/nrcardio.2011.50

Pentraxin 3-a marker of diastolic dysfunction and HF?

Bernhard M. Kaess, Ramachandran S. Vasan

Producción científica: Article › revisión exhaustiva

24 Citas (Scopus)

Resumen

Inflammation has a pivotal role in cardiac remodeling, and circulating biomarkers of inflammation are independently associated with risk of developing heart failure and with prognosis after onset of the condition. Pentraxin 3 has been suggested as a novel biomarker of left ventricular diastolic dysfunction and heart failure with normal ejection fraction.

Idioma original	English (US)
Páginas (desde-hasta)	246-248
Número de páginas	3
Publicación	Nature Reviews Cardiology
Volumen	8
N.º	5
DOI	https://doi.org/10.1038/nrcardio.2011.50
Estado	Published - may 2011
Publicado de forma externa	Sí

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Acceder al documento

10.1038/nrcardio.2011.50

Otros archivos y enlaces

Citar esto

@article{ff4a341a9fd644fc83f363047a1e577d,

title = "Pentraxin 3-a marker of diastolic dysfunction and HF?",

abstract = "Inflammation has a pivotal role in cardiac remodeling, and circulating biomarkers of inflammation are independently associated with risk of developing heart failure and with prognosis after onset of the condition. Pentraxin 3 has been suggested as a novel biomarker of left ventricular diastolic dysfunction and heart failure with normal ejection fraction.",

author = "Kaess, \{Bernhard M.\} and Vasan, \{Ramachandran S.\}",

year = "2011",

month = may,

doi = "10.1038/nrcardio.2011.50",

language = "English (US)",

volume = "8",

pages = "246--248",

journal = "Nature Reviews Cardiology",

issn = "1759-5002",